Emerging Infectious Diseases
Severe Acute Respiratory Syndrome (SARS) Funding Opportunities
SARS-CoV has been added to the NIAID list of Category C Priority Pathogens as of August 30, 2004.
The Division of Microbiology and Infectious Diseases (DMID) offers a number of
funding opportunities for researchers interested in SARS. Please refer to the
list below for specific information.
Supporting basic research is an integral part of NIAID's comprehensive research agenda for SARS and other emerging infectious diseases. The FY 2003 Awards chart lists DMID-funded grants for basic coronavirus research that received supplemental funding in response to the SARS outbreak of 2002-2003.
Current Opportunities
NIH Exploratory/Developmental Research Grant Award (R21)
Detailed
announcement PA03-107
-
Receipt Dates: February 1, June 1, October 1 (dates are the
same each year)
-
Current Focus: The R21 mechanism is intended to encourage new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models or applications that could have major impact on a field of biomedical, behavioral, or clinical research.
-
Contact Person:
Scott Winram
NIH Small Research Grant Program (R03)
Detailed
announcement PA03-108
-
Receipt Dates: February 1, June 1, October 1 (dates are the
same each year)
-
Current Focus: The R03 award supports small research projects
that can be carried out in a short period of time with limited resources. SARS
applications are responsive.
-
Contact Persons:
Carl W. Dieffenbach
Sam Perdue
Alison Deckhut
Small Business Innovation Research (SBIR)
and Small Business Technology Transfer (STTR) Grants
Detailed
announcement for SBIR/STTR
-
Receipt Dates: April 1, August 1, December 1 (dates are the
same each year)
-
Current Focus: SARS applications are responsive.
-
Contact Person:
Barbara Mulach
SBIR Advanced Technology - NIAID
(SBIR-AT-NIAID)
Detailed
announcement PA-01-052
SARS applications are responsive. Advanced technology projects are defined as
those that include high-cost advanced technology or high-cost long-term
clinical studies in human or non-human primates. NIAID invites applications for
SBIR-AT-NIAID awards in three areas:
-
Development of vaccines, biologics, drugs and prevention strategies for
infectious and immunologic diseases, allergy, and transplantation.
-
Development of vaccine, biologic and drug delivery systems.
-
Development of assays and therapeutic monitoring systems for clinical and
vaccine trials and for improved diagnosis of infectious, allergic, and
immunologic diseases.
Contact Person: Barbara Mulach
NIAID offers "SARS" Chip free to
Researchers
Press release with detailed information
Application information
-
Receipt date: Applications are being accepted on a continuous
basis
-
Current Focus: NIAID will distribute SARS
microarrays-essentially a reference strain of the SARS coronavirus embedded in
a quartz chip-at no cost to qualified researchers worldwide. Distribution of
the GeneChip(r) brand SARS Array, made by Affymetrix, Inc., will be coordinated
by the NIAID's Pathogen Functional Genomics Resource Center (PFGRC). Any
researcher can request the SARS Array using a simple Web-based application
process.
-
Contact Person: Maria
Giovanni
Top of Page
